I.M. Sechenov First Moscow State Medical University

🇷🇺Russia

Country: 🇷🇺Russia

Ownership: Private

Established: 1758-01-01

Employees: 5K

Market Cap: -

Website: http://www.mma.ru

Clinical Trials

Micro-RNA Profile in Patients With Different Stages of Atherosclerosis According to CTA

Not Applicable

Completed

Conditions: Atherosclerosis
Ischemic Heart Disease

Interventions: Diagnostic Test: blood test

First Posted Date: 2019-02-27

Last Posted Date: 2020-12-22

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 81

Registration Number: NCT03855891

Locations: 🇷🇺
IMSechenovMMA, Moscow, Russian Federation

Benign Prostatic Hyperplasia and Ischemic Heart DIsease

Phase 4

Completed

Conditions: Ischaemic Heart Disease (IHD)
Benign Prostatic Hyperplasia (BPH)
Lower Urinary Tract Symptoms (LUTS)

Interventions: Drug: Tamsulosin Oral Capsule
Procedure: TURP

First Posted Date: 2019-02-27

Last Posted Date: 2019-02-27

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 83

Registration Number: NCT03856242

One-Dimensional Mathematical Model-Based Automated Assessment of Fractional Flow Reserve

Not Applicable

Completed

Conditions: Coronary Artery Disease

Interventions: Device: FFR

First Posted Date: 2019-01-08

Last Posted Date: 2020-05-18

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 31

Registration Number: NCT03797118

Locations: 🇷🇺
Daria Gognieva, Moscow, Russian Federation

Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP): Efficacy and Safety

Not Applicable

Conditions: Prostatic Hyperplasia

Interventions: Procedure: Thulium Fiber Laser Enucleation of the Prostate
Device: Thulium Fiber Laser "Urolase"

First Posted Date: 2018-06-12

Last Posted Date: 2021-07-22

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 500

Registration Number: NCT03554070

Locations: 🇷🇺
Clinic of Urology, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation

Efficacy and Safety Assessment of IRE of Localized Prostate Cancer.

Not Applicable

Completed

Conditions: Prostate Adenocarcinoma
Prostate Cancer

Interventions: Device: Focal irreversible electroporation of the prostate cancer

First Posted Date: 2018-04-20

Last Posted Date: 2020-07-28

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 10

Registration Number: NCT03504995

Locations: 🇷🇺
Clinic of Urology, Sechenov University, Moscow, Russian Federation

Effectiveness of BBT-I and Zopiclone for Chronic Insomnia

Phase 2

Completed

Conditions: Insomnia Chronic

Interventions: Behavioral: Brief behavioral therapy
Drug: Zopiclone

First Posted Date: 2017-11-13

Last Posted Date: 2019-09-16

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 42

Registration Number: NCT03339583

ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPH

Not Applicable

Completed

Conditions: Prostatic Hyperplasia, Benign
Lower Urinary Tract Symptoms
Prostate Adenoma

Interventions: Procedure: Monopolar enucleation of the prostate
Procedure: Thulium-fiber laser enucleation of the prostate

First Posted Date: 2017-07-26

Last Posted Date: 2017-07-28

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 450

Registration Number: NCT03230721

Tissue-engineered Construct Based on Buccal Mucosa Cells and Matrix From Collagen and Polylactoglycolide Fibers

Early Phase 1

Conditions: Urethral Stricture

Interventions: Procedure: Urethroplasty with a tissue-engineered construct

First Posted Date: 2017-07-02

Last Posted Date: 2020-02-17

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 6

Registration Number: NCT03205670

Locations: 🇷🇺
Sechenov University, Moscow, Russian Federation

Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B by Women With Climacteric Syndrome

Not Applicable

Completed

Conditions: Menopause
Climacteric Syndrome

Interventions: Dietary Supplement: Placebo
Dietary Supplement: Amberen
Dietary Supplement: Smart B

First Posted Date: 2017-04-18

Last Posted Date: 2017-10-20

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 107

Registration Number: NCT03118908

Locations: 🇷🇺
Sechenov First Moscow Medical University, Moscow, Russian Federation

A Pooled Analysis of the Data From Two Studies of Ammonium Succinate for Menopausal Symptoms

Completed

Conditions: Menopause Related Conditions

Interventions: Other: Placebo
Dietary Supplement: Ammonium succinate

First Posted Date: 2017-02-06

Last Posted Date: 2017-10-20

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 227

Registration Number: NCT03043690

Locations: 🇷🇺
Sechenov First Moscow Medical University, Moscow, Russian Federation

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy